# TRIM39

## Overview
TRIM39 is a gene that encodes the protein tripartite motif containing 39, which is a member of the tripartite motif (TRIM) family. This family is characterized by a conserved domain structure that includes a RING domain, B-box domains, and a coiled-coil region, which are typical features of E3 ubiquitin ligases (Lee2009TRIM39). The TRIM39 protein plays a crucial role in regulating apoptosis and cell cycle progression by modulating the stability of key proteins such as MOAP-1, thereby influencing apoptotic pathways (Huang2012The). Additionally, TRIM39 is involved in various cellular interactions, including those with Rab7 and peroxiredoxin 3, impacting processes like autophagy and oxidative stress (Hu2021TRIM39; Jian2024The). The gene's expression and function have significant implications in diseases such as colorectal cancer, renal fibrosis, and nasopharyngeal carcinoma, highlighting its potential as a therapeutic target (Ning2020Nasopharyngeal; Hu2021TRIM39; Jian2024The).

## Structure
TRIM39, also known as Ring Finger Protein 23 (RNF23), is a member of the tripartite motif (TRIM) family characterized by a specific molecular structure. This structure includes a RING domain, one or two zinc-binding B-box domains, and a coiled-coil region (Lee2009TRIM39). The RING domain is composed of eight cysteine and histidine residues arranged to coordinate two zinc atoms, a feature common in many E3 ubiquitin ligases, which is crucial for mediating interactions with E2 proteins and subsequent substrate ubiquitination (Lee2009TRIM39). TRIM39 also contains a C-terminal B30.2 domain, which includes PRY and SPRY domains (Lee2009TRIM39).

The protein is predominantly localized in the cytosol and does not co-localize with nuclear, Golgi, or mitochondrial markers, but partially co-localizes with the endoplasmic reticulum marker PDI (Lee2009TRIM39). TRIM39 interacts with MOAP-1, stabilizing it by inhibiting its poly-ubiquitination, which suggests a role in apoptosis regulation (Lee2009TRIM39). The B-box domain is essential for its interaction with Cactin, a protein involved in the NFκB-mediated signaling pathway (Suzuki2015TRIM39). Despite its potential E3 ligase activity, TRIM39 stabilizes MOAP-1 rather than promoting its degradation (Lee2009TRIM39).

## Function
TRIM39 is a protein that plays a significant role in regulating apoptosis and cell cycle progression in healthy human cells. It functions as an E3 ubiquitin ligase, inhibiting the anaphase-promoting complex/cyclosome (APC/C), specifically its interaction with the Cdh1 coactivator. This inhibition prevents the degradation of MOAP-1, a pro-apoptotic protein that interacts with Bax, thereby stabilizing MOAP-1 and enhancing apoptosis (Huang2012The).

TRIM39 stabilizes MOAP-1 by inhibiting its poly-ubiquitination, which would otherwise lead to its degradation by the ubiquitin-proteasome system. This stabilization is crucial for sensitizing cells to apoptotic stimuli, such as etoposide, by facilitating Bax-mediated cytochrome c release from mitochondria (Lee2009TRIM39). The protein is predominantly localized in the cytosol and does not co-localize with nuclear, Golgi, or mitochondrial markers, but shows partial co-localization with the endoplasmic reticulum (Lee2009TRIM39).

TRIM39's role in apoptosis and cell cycle regulation suggests its importance in maintaining cellular homeostasis and responding to stress conditions, potentially offering therapeutic strategies for enhancing apoptosis in cancer cells (Huang2012The; Lee2009TRIM39).

## Clinical Significance
TRIM39 has been implicated in several diseases due to its role in regulating cellular processes. In colorectal cancer (CRC), TRIM39 is upregulated and associated with poor prognosis. It promotes tumor growth by enhancing autophagic flux through its interaction with Rab7, a key regulator of autophagosome maturation. TRIM39 deficiency leads to impaired autophagic flux and inhibits tumor progression, suggesting its potential as a therapeutic target in CRC (Hu2021TRIM39).

In renal fibrosis, TRIM39 expression is elevated and contributes to disease progression by promoting oxidative stress. It interacts with peroxiredoxin 3 (PRDX3), leading to its ubiquitination and degradation, which results in increased reactive oxygen species (ROS) and inflammation. Knockdown of TRIM39 alleviates fibrosis, indicating its role in exacerbating renal damage (Jian2024The).

TRIM39 is also linked to nasopharyngeal carcinoma (NPC), where it is associated with reduced risk. Genetic studies have identified TRIM39 as a non-HLA gene involved in NPC risk reduction, suggesting its involvement in immune response regulation and tumor suppression (Ning2020Nasopharyngeal). These findings highlight TRIM39's diverse roles in cancer and fibrosis, making it a potential target for therapeutic interventions.

## Interactions
TRIM39, a member of the tripartite motif (TRIM) family, is involved in several protein interactions that influence cellular processes. One significant interaction is with Rab7, a protein crucial for autophagosome maturation. TRIM39 inhibits the ubiquitination of Rab7 at the lysine 191 residue, enhancing Rab7's activity by promoting its interaction with MON1A. This interaction is independent of TRIM39's E3 ubiquitin ligase activity and is crucial for colorectal cancer progression and autophagic flux (Hu2021TRIM39).

TRIM39 also interacts with MOAP-1, a pro-apoptotic protein. It stabilizes MOAP-1 by inhibiting its poly-ubiquitination, thereby preventing its degradation. This stabilization enhances MOAP-1's role in apoptosis, particularly in sensitizing cells to etoposide-induced apoptosis and promoting Bax-mediated cytochrome c release from mitochondria (Lee2009TRIM39).

In the context of renal fibrosis, TRIM39 interacts with peroxiredoxin 3 (PRDX3), a mitochondrial protein involved in reducing oxidative stress. TRIM39 mediates the ubiquitination and degradation of PRDX3, leading to increased reactive oxygen species and exacerbation of renal fibrosis (Jian2024The). These interactions highlight TRIM39's role in modulating various cellular pathways through its interactions with other proteins.


## References


[1. (Lee2009TRIM39) San San Lee, Nai Yang Fu, Sunil K. Sukumaran, Kah Fei Wan, Qian Wan, and Victor C. Yu. Trim39 is a moap-1-binding protein that stabilizes moap-1 through inhibition of its poly-ubiquitination process. Experimental Cell Research, 315(7):1313–1325, April 2009. URL: http://dx.doi.org/10.1016/j.yexcr.2008.11.021, doi:10.1016/j.yexcr.2008.11.021. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2008.11.021)

[2. (Ning2020Nasopharyngeal) Lvwen Ning, Josephine Mun-Yee Ko, Valen Zhuoyou Yu, Hoi Yan Ng, Candy King-Chi Chan, Lihua Tao, Shiu-Yeung Lam, Merrin Man-Long Leong, Roger Kai-Cheong Ngan, Dora Lai-Wan Kwong, Anne Wing-Mui Lee, Wai-Tong Ng, Ashley Cheng, Stewart Tung, Victor Ho-Fun Lee, Ka-On Lam, Chung-Kong Kwan, Wing-Sum Li, Stephen Yau, Jin-Xin Bei, and Maria Li Lung. Nasopharyngeal carcinoma mhc region deep sequencing identifies hla and novel non-hla trim31 and trim39 loci. Communications Biology, December 2020. URL: http://dx.doi.org/10.1038/s42003-020-01487-y, doi:10.1038/s42003-020-01487-y. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-020-01487-y)

[3. (Jian2024The) Jun Jian, Yunxun Liu, Qingyuan Zheng, Jingsong Wang, Zhengyu Jiang, Xiuheng Liu, Zhiyuan Chen, Shanshan Wan, Hao Liu, and Lei Wang. The e3 ubiquitin ligase trim39 modulates renal fibrosis induced by unilateral ureteral obstruction through regulating proteasomal degradation of prdx3. Cell Death Discovery, January 2024. URL: http://dx.doi.org/10.1038/s41420-023-01785-4, doi:10.1038/s41420-023-01785-4. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-023-01785-4)

[4. (Suzuki2015TRIM39) Masanobu Suzuki, Masashi Watanabe, Yuji Nakamaru, Dai Takagi, Hidehisa Takahashi, Satoshi Fukuda, and Shigetsugu Hatakeyama. Trim39 negatively regulates the nfκb-mediated signaling pathway through stabilization of cactin. Cellular and Molecular Life Sciences, 73(5):1085–1101, September 2015. URL: http://dx.doi.org/10.1007/s00018-015-2040-x, doi:10.1007/s00018-015-2040-x. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-015-2040-x)

[5. (Hu2021TRIM39) Jia Hu, Xueliang Ding, Shaobo Tian, Yanan Chu, Zhibo Liu, Yuqin Li, Xiaoqiong Li, Guobin Wang, Lin Wang, and Zheng Wang. Trim39 deficiency inhibits tumor progression and autophagic flux in colorectal cancer via suppressing the activity of rab7. Cell Death &amp; Disease, April 2021. URL: http://dx.doi.org/10.1038/s41419-021-03670-3, doi:10.1038/s41419-021-03670-3. This article has 25 citations.](https://doi.org/10.1038/s41419-021-03670-3)

[6. (Huang2012The) Nai-Jia Huang, Liguo Zhang, Wanli Tang, Chen Chen, Chih-Sheng Yang, and Sally Kornbluth. The trim39 ubiquitin ligase inhibits apc/ccdh1-mediated degradation of the bax activator moap-1. Journal of Cell Biology, 197(3):361–367, April 2012. URL: http://dx.doi.org/10.1083/jcb.201111141, doi:10.1083/jcb.201111141. This article has 55 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201111141)